Kyle is an associate in Ropes & Gray’s litigation & enforcement group. He focuses his practice on antitrust and anti-corruption and international risk—including white-collar criminal defense, cross-border internal investigations, and sanctions and export control.
Kyle has represented companies under investigation by the DOJ, SEC, CFTC, and FTC. He has extensive experience in the pharmaceutical, medical device, and financial sectors, routinely advising clients in connection with matters involving alleged violations of anti-bribery/corruption and sanctions and export control laws and guiding clients on antitrust compliance and risk. He also maintains a robust pro bono practice, representing clients in a variety of matters.
Before joining the firm in 2019, Kyle clerked for the Honorable Thomas C. Wheeler of the U.S. Court of Federal Claims in Washington, D.C. and worked at another international law firm focusing on civil and criminal government enforcement actions and internal investigations.
Experience
Antitrust
- Represented Nippon Steel Corporation in obtaining successful antitrust clearance from the DOJ for its historic $14.9 billion acquisition of U.S. Steel Corporation.
- Represented pharmaceutical and medical device companies in navigating Second Requests and ultimately obtaining successful antitrust clearance from the FTC on those transactions.
- Represented numerous private equity clients on antitrust compliance and risk in proposed mergers, acquisitions, and investments in portfolio companies.
- Represented clients involved as third parties in merger litigations brought by FTC in FTC v. IQVIA Holdings Inc., et al. and FTC v. GTCR BC Holdings, LLC et al.
- Represented a life sciences client by conducting internal investigations into allegations of anti-competitive conduct, including competitively sensitive information sharing and “no-poach” agreements.
Anti-Corruption/International Risk
- Represented a large financial institution in connection with a civil enforcement action by the CFTC.*
- Represented a major auditing firm under investigation by a state Attorney General.*
- Represented an individual involved in the DOJ’s investigation of major international corruption scandal resulting in no action against the client.
- Represented a real estate investment firm during SEC examination resulting in no action against the client.
- Represented a global pharmaceutical and medical device manufacturer on a host of trade compliance issues, including conducting a risk assessment of the enterprise's global trade compliance program, helping to develop and implement fulsome compliance guidance and programmatic enhancements, and leading a comprehensive internal investigation related to sanctions and export controls.
- Represented multiple leading pharmaceutical and medical technology clients in cross-border internal and regulatory investigations throughout Europe, the Middle East, and Latin America. This included alleged violations of the FCPA, UK Bribery Act, anti-competition laws, privacy laws, and internal compliance policies and procedures.
- Represented clients in the pharmaceutical, medical technology, technology, and financial sectors on development of new or enhancement of existing compliance frameworks, including policies, procedures, training programs, investigative protocols, and enterprise risk reporting mechanisms.
- Represented a client in the energy industry by conducting an internal investigation into corporate fraud and misappropriation of corporate assets-related issues.
*Experience prior to joining Ropes & Gray